Data News > Stocks with Regular Dividends: Top gainers HON, CLX, MRK, BMY, COST

Stocks with Regular Dividends: Top gainers HON, CLX, MRK, BMY, COST

By KlickAnalytics Data Insights  |   April 29, 2025 04:39PM ET

Following are the Top 5 companies based on their one-day percentage change within the 'Stocks with Regular Dividends' theme.

Honeywell International Inc. (HON)

HON is trading UP for the last 2 days, and it at trading at $211.59 with volume of 6,443,889 and a one day change of $10.93 (5.45%). Honeywell International Inc. has a 52-week low of 180.50 and a 52-week high of $240.30. The business's 50-day moving average price is $205.69 and its 200 day moving average price is $210.97. The firm has a market cap of $127 million, a P/E ratio of 23.54, and a beta of 1.00.

Top news headlines for HON

  • Honeywell International Inc. (NASDAQ:HON ) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Company Participants Sean Meakim - VP of IR Vimal Kapur - Chairman and CEO Mike Stepniak - SVP and CFO Conference Call Participants Nigel Coe - Wolfe Research Steve Tusa - JPMorgan Julian Mitchell - Barclays Scott Davis - Melius Research Andrew Obin - Bank of America Sheila Kahyaoglu - Jefferies Amit Mehrotra - UBS Joe Ritchie - Goldman Sachs Chris Snyder - Morgan Stanley Andy Kaplowitz - Citigroup Operator Thank you for standing by and welcome to the Honeywell First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
  • HON's first-quarter results benefit from growth in commercial aftermarket, defense & space and warehouse and workflow solutions. Softness across the safety & sensing technologies businesses hurts results.
  • U.S. equities were higher at midday as markets waited for further clarification from the Trump administration about possible changes in tariff policy. The Dow Jones Industrial Average rose 0.6%, and the S&P 500 and Nasdaq were up by smaller percentages.
  • Honeywell International (HON 5.57%) reported first-quarter earnings that topped expectations and the company raised its full-year profit forecast. Investors were pleased, sending Honeywell shares up 5% as of 10:30 am ET.
  • Although the revenue and EPS for Honeywell International (HON) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

  • For more information on HON:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • The Clorox Company (CLX)

    CLX is trading UP for the last 3 days, and it at trading at $141.25 with volume of 1,565,660 and a one day change of $2.47 (1.78%). The Clorox Company has a 52-week low of 124.23 and a 52-week high of $168.60. The business's 50-day moving average price is $144.86 and its 200 day moving average price is $151.61. The firm has a market cap of $17 million, a P/E ratio of 73.89, and a beta of 0.60.

    For more information on CLX:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • Merck & Co., Inc. (MRK)

    MRK is trading UP for the last 4 days, and it at trading at $84.65 with volume of 10,149,061 and a one day change of $1.46 (1.76%). Merck & Co., Inc. has a 52-week low of 76.76 and a 52-week high of $131.54. The business's 50-day moving average price is $86.97 and its 200 day moving average price is $100.82. The firm has a market cap of $197 million, a P/E ratio of 144.51, and a beta of 0.42.

    Top news headlines for MRK

  • The new facility will produce biologic drugs and Keytruda, becoming Merck's first in-house US site to make the blockbuster cancer treatment, the company said.
  • RAHWAY, N.J.--(BUSINESS WIRE)--Merck Breaks Ground on New $1 billion Biologics Center of Excellence in Wilmington, Delaware.
  • U.S. drugmaker Merck is investing $1 billion in a new Delaware plant to expand its domestic production as it prepares to deal with the looming impact from President Donald Trump's tariffs, the Wall Street Journal reported on Tuesday.
  • The Delaware facility will ensure a domestic supply of biologic drugs including the cancer drug Keytruda.

  • For more information on MRK:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • Bristol-Myers Squibb Company (BMY)

    BMY is trading UP for the last 2 days, and it at trading at $49.22 with volume of 12,342,441 and a one day change of $0.76 (1.56%). Bristol-Myers Squibb Company has a 52-week low of 38.26 and a 52-week high of $62.65. The business's 50-day moving average price is $55.96 and its 200 day moving average price is $52.87. The firm has a market cap of $101 million, a P/E ratio of 0.00, and a beta of 0.41.

    Top news headlines for BMY

  • Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

  • For more information on BMY:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • Costco Wholesale Corporation (COST)

    COST is trading UP for the last 3 days, and it at trading at $992.19 with volume of 1,191,787 and a one day change of $13.65 (1.39%). Costco Wholesale Corporation has a 52-week low of 719.49 and a 52-week high of $1,078.23. The business's 50-day moving average price is $971.23 and its 200 day moving average price is $926.74. The firm has a market cap of $442 million, a P/E ratio of 51.55, and a beta of 0.94.

    Top news headlines for COST

  • Jessica Inskip urges investors to keep tariff volatility in mind when adjusting your portfolio. She talks investors through how Fastenal (FAST), Costco (COST), and Berkshire Hathaway (BRK/B) offer piece of mind as volatility stays high.
  • As far as mega-cap retailers are concerned, Costco (NASDAQ:COST) and Walmart (NYSE:WMT) are the two big dogs in this sector most investors should be paying closest attention to.

  • For more information on COST:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • This article was generated by KlickAnalytics data insight content engine.

    Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.